comparemela.com

Latest Breaking News On - Global rare - Page 7 : comparemela.com

Sunshine Homes chiếm trọn làn sóng bất động sản hạng sang Tây Hồ Tây với 600 villas đẳng cấp

Sunshine Homes chiếm trọn làn sóng bất động sản hạng sang Tây Hồ Tây với 600 villas đẳng cấp
kinhtedothi.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kinhtedothi.vn Daily Mail and Mail on Sunday newspapers.

Chiesi Global Rare Diseases Announces FDA Approval of FERRIPROX® (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

Published: May 01, 2021 Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia BOSTON, May 1, 2021 /PRNewswire/ Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today that the U.S. Food & Drug Administration (FDA) has approved FERRIPROX ® (deferiprone) for the treatment of transfusional iron overload due to sickle cell disease (SCD) or other anemias in adult and pediatric patients 3 years of age and older. This FDA approval expands the use of FERRIPROX for patients with SCD or other anemias as well as patients with thalassemia regardless of prior iron chelation exposure.

Điện kính thiên Còn nhiều dấu hỏi nghiên cứu về kinh đô hoa lệ nghìn năm

Điện kính thiên Còn nhiều dấu hỏi nghiên cứu về kinh đô hoa lệ nghìn năm
thethaovanhoa.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thethaovanhoa.vn Daily Mail and Mail on Sunday newspapers.

Chiesi Global Rare Diseases Announces FDA Approval of FERRIPROX® (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

Chiesi Global Rare Diseases Recognizes Rare Disease Day Highlighting Importance of Staying Connected for Information and Support

Chiesi Global Rare Diseases Recognizes Rare Disease Day Highlighting Importance of Staying Connected for Information and Support Company sponsors #wewearstripes social media campaign calling on participants to share photos to express support for people affected by rare diseases Company to light up offices around the world including Italy, the United States, and Canada News provided by Share this article Share this article BOSTON, Feb. 26, 2021 /PRNewswire/  Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), is recognizing Rare Disease Day (RDD) 2021 and joins with the global community to support efforts to help patients and families affected by rare diseases to stay connected and access the support and information they need.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.